CS
NARI

Credit Suisse’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Credit Suisse’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$61.7M Buy
1,286,156
+115,662
+10% +$6.18M 0.06% 321
2023
Q4 		$76M Buy
1,170,494
+14,053
+1% +$846K 0.07% 268
2023
Q3 		$75.6M Sell
1,156,441
-32,525
-3% -$2.05M 0.08% 258
2023
Q2 		$69.1M Buy
1,188,966
+30,169
+3% +$1.9M 0.07% 296
2023
Q1 		$71.5M Buy
1,158,797
+357,843
+45% +$21.5M 0.07% 284
2022
Q4 		$50.9M Buy
800,954
+250,584
+46% +$18.2M 0.05% 388
2022
Q3 		$40M Buy
550,370
+2,645
+0.5% +$197K 0.04% 447
2022
Q2 		$37.2M Buy
547,725
+19,218
+4% +$1.38M 0.04% 491
2022
Q1 		$47.9M Sell
528,507
-147,039
-22% -$12M 0.04% 454
2021
Q4 		$61.7M Buy
675,546
+46,928
+7% +$4.02M 0.03% 541
2021
Q3 		$51M Sell
628,618
-8,345
-1% -$701K 0.03% 634
2021
Q2 		$59.4M Buy
636,963
+329,405
+107% +$31.9M 0.03% 595
2021
Q1 		$32.9M Buy
307,558
+254,651
+481% +$26.4M 0.02% 903
2020
Q4 		$4.62M Buy
+52,907
New +$3.74M ﹤0.01% 2158

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Credit Suisse's NARI Position: Q1 2024 in Review

Credit Suisse increased its Inari Medical, Inc. Common Stock (NARI) stake by 9.9% in Q1 2024, buying an estimated $6.18M and bringing the position to 1,286,156 shares worth $61.7M. The position accounts for 0.06% of the portfolio, ranked #321.

Credit Suisse first reported a position in NARI in Q4 2020 and has held it in 14 quarters since. The position peaked at $76M in Q4 2023. 231 funds tracked by Wall St. Rank hold NARI as of Q1 2024.

  • Credit Suisse held 1,286,156 shares of Inari Medical, Inc. Common Stock worth $61.7M as of Q1 2024.
  • Credit Suisse bought 115,662 Inari Medical, Inc. Common Stock shares in Q1 2024, an estimated $6.18M.
  • Inari Medical, Inc. Common Stock made up 0.06% of Credit Suisse's portfolio in Q1 2024, its #321 holding.
  • Credit Suisse first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and has held it in 14 quarters since.
  • Credit Suisse's Inari Medical, Inc. Common Stock position peaked at $76M in Q4 2023.
  • 231 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.